• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公众参与:导论

Public Participation: An Introduction.

作者信息

Grant R Alexander

机构信息

Food and Drug Administration, 5600 Fishers Lane, Rockville, Maryland 20857.

出版信息

J Food Prot. 1980 May;43(5):410-413. doi: 10.4315/0362-028X-43.5.410.

DOI:10.4315/0362-028X-43.5.410
PMID:30822882
Abstract

Public participation has become an increasingly important activity within the Food and Drug Administration (FDA). Translating a concept such as public participation into an operational reality, however, presents a constant challenge to federal as well as state and local governments. FDA has developed a model Public Participation Program that provides a variety of ways for consumers to become involved in the Agency's decisionmaking process. The FDA program is policy oriented and strives to achieve five basic objectives. The ultimate goal of this program is to provide consumers with the opportunity to participate in and impact on the Agency's decisions concerning important health issues. Realizing this goal will enable the Agency to ensure that its policies and regulations are responsive to expressed consumer concerns.

摘要

公众参与在食品药品监督管理局(FDA)内部已成为一项日益重要的活动。然而,将公众参与这样的概念转化为实际行动,对联邦政府以及州和地方政府来说始终是一项挑战。FDA制定了一个模范公众参与计划,为消费者提供了多种参与该机构决策过程的方式。FDA的计划以政策为导向,力求实现五个基本目标。该计划的最终目标是为消费者提供机会,使其能够参与并影响该机构有关重要健康问题的决策。实现这一目标将使该机构能够确保其政策和法规回应消费者表达的关切。

相似文献

1
Public Participation: An Introduction.公众参与:导论
J Food Prot. 1980 May;43(5):410-413. doi: 10.4315/0362-028X-43.5.410.
2
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
3
Evaluating public participation in environmental decision-making: EPA's superfund community involvement program.评估公众参与环境决策:美国环境保护局的超级基金社区参与计划。
J Environ Manage. 2005 Nov;77(3):165-82. doi: 10.1016/j.jenvman.2005.04.002. Epub 2005 Aug 22.
4
5
New drug and antibiotic regulations--FDA. Proposed rule.
Fed Regist. 1982 Oct 19;47(202):46622-66.
6
Culture of Care: Organizational Responsibilities关怀文化:组织职责
7
Regulation of prescription drug promotion: direct-to-consumer advertising.处方药促销监管:面向消费者的直接广告
Clin Ther. 1998;20 Suppl C:C86-95. doi: 10.1016/s0149-2918(98)80012-x.
8
Regulatory beneficiaries and informal agency policymaking.监管受益者与非正式机构决策制定
Cornell Law Rev. 2007 Mar;92(3):397-452.
9
Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control.研讨会介绍:《烟草控制法案》十年:进展、挫折与烟草控制的未来。
J Leg Med. 2020 Jul-Dec;40(3-4):285-291. doi: 10.1080/01947648.2020.1867474.
10
Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.适用于血液、血液成分和原料血浆的要求修订。卫生与公众服务部(HHS),公共卫生服务部(PHS),食品药品监督管理局(FDA)。直接最终规则。
Fed Regist. 1999 Aug 19;64(160):45366-74.